Tazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma
Clinical trial NCT05994235 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05994235
- Sponsor
- Weill Medical College of Cornell University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2033-10-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.